Lacklustre trading was seen Dr Reddy's Laboratories shares ahead of its quarterly earnings announcements, later today. The stock was trading at Rs 4,475.10 on the NSE around 12:45 am and were down by Rs 16.10 or 0.36 per cent from the Thursday closing price, tracking movement of the pharma sector. Nifty Pharma was one of the top laggards today and was down 0.79 per cent around this time.

COMMERCIAL BREAK
SCROLL TO CONTINUE READING

The stock has seen an upward move over the past four trading sessions. 

The stock was trading with moderate volumes.  

 

Stock Markets Today LIVE UPDATES: Sensex slips after hitting 60000, Nifty50 below 17800; pharma, metals among major drags

The domestic growth is expected to remain moderate. US business is expected to grow by 2 per cent YoY. 

The stock has given 3,38 per cent returns over the last three months.

Analyst Sandeep Jain recommends a 'Hold' on Dr Reddy's shares calling it a good stock. The stock has gained over the past 4 trading sessions and hence no fresh buying position should be made, he said. His suggestion to investors is to wait for the results.

The Tradeswift Director is positive on the overall pharma sector calling it an underperformer amongst its peers. 

SBI Cards shares see sharp slip after brokerages slash targets

(Disclaimer: The views/suggestions/advises expressed here in this article is solely by investment experts. Zee Business suggests its readers to consult with their investment advisers before making any financial decision.)